In the largest study of its kind, researchers at the Southwest Foundation for Biomedical Research have found that exposure to cigarette smoke can alter gene expression — the process by which a gene’s information is converted into the structures and functions of a cell. These alterations in response to smoking appear to have a wide-ranging negative influence on the immune system, and a strong involvement in processes related to cancer, cell death and metabolism. Continue Reading
Experts believe diabetes will be the leading disease in Asia mainly because of the rise in consumption of junk and high calorie foods in this region of the world. Continue Reading
The future health of offspring is more negatively impacted when their mothers consume a high fat diet while nursing compared with high-fat diet consumption during pregnancy, according to animal research at Johns Hopkins University. These new research results are being presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior. Continue Reading
Opposition Leader Tony Abbott announced last Saturday that he would be rolling out a $35 million funding for a clinical trial network (CTN) to improve the health of Australians with diabetes if he is elected as Prime Minister. The Rudd Governments $5million to the CTN will be supplemented by these funds. “This is one Coalition commitment I would be very happy for the government to match,” he said. Continue Reading
Wound Management Technologies, Inc. announced an important milestone in its planned growth strategy. Its wholly owned subsidiary Wound Care Innovations signed a distribution agreement with KOMED, LLC of Georgia for direct response advertising on television and niche online marketing of CellerateRx® in the United States. Continue Reading
People with type 1 diabetes who have early and asymptomatic kidney damage, as indicated by small amounts of protein in the urine, are six times more likely to die compared to the general population, say researchers at the University of Pittsburgh Graduate School of Public Health. Their study, being presented at the 70th Scientific Sessions of the American Diabetes Association, also found that when kidneys remained normal over time, people with type 1 diabetes had no greater risk of death than their healthy counterparts. Continue Reading
Metabolon, Inc., the leader in metabolomics-based biomarker discovery and analysis, today announced the publication of research that identified a novel, early biomarker for insulin resistance and glucose intolerance in a nondiabetic population. Continue Reading
Complex wounds affect more patients in the United States than heart attack and stroke combined. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease. There are currently no established methods for early detection of wound healing, or for precise identification of healing progress. Continue Reading
The new health law contains “many opportunities to nudge people toward better health choices. … ‘In healthcare, for years and years and years there’s been an interest in changing provider and consumer behavior,’” says Stanford professor Alan Garber. “What’s new is that money is flowing into research on behavioral economics, and the government is getting involved, Garber and others said. Continue Reading
Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8 mm Hg versus 27.5 to 30.0/15.1-18.0 mm Hg LS Mean Reductions, P< 0.0001), as compared to corresponding dual combination therapy (dual components). Continue Reading
